0001213900-14-008789.txt : 20141208
0001213900-14-008789.hdr.sgml : 20141208
20141208165403
ACCESSION NUMBER: 0001213900-14-008789
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20141204
FILED AS OF DATE: 20141208
DATE AS OF CHANGE: 20141208
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: SOLIGENIX, INC.
CENTRAL INDEX KEY: 0000812796
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 411505029
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 29 EMMONS DRIVE
STREET 2: SUITE C-10
CITY: PRINCETON
STATE: NJ
ZIP: 08540
BUSINESS PHONE: 609-538-8200
MAIL ADDRESS:
STREET 1: 29 EMMONS DRIVE
STREET 2: SUITE C-10
CITY: PRINCETON
STATE: NJ
ZIP: 08540
FORMER COMPANY:
FORMER CONFORMED NAME: DOR BIOPHARMA INC
DATE OF NAME CHANGE: 20020329
FORMER COMPANY:
FORMER CONFORMED NAME: ENDOREX CORP
DATE OF NAME CHANGE: 19960916
FORMER COMPANY:
FORMER CONFORMED NAME: IMMUNOTHERAPEUTICS INC
DATE OF NAME CHANGE: 19920703
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Straube Richard
CENTRAL INDEX KEY: 0001595197
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-16929
FILM NUMBER: 141273026
MAIL ADDRESS:
STREET 1: 29 EMMONS DRIVE, SUITE C-10
CITY: PRINCETON
STATE: NJ
ZIP: 08540
4
1
f4120414straube_soligenix.xml
OWNERSHIP DOCUMENT
X0306
4
2014-12-04
0
0000812796
SOLIGENIX, INC.
SNGX
0001595197
Straube Richard
29 EMMONS DRIVE, SUITE C-10
PRINCETON
NJ
08540
0
1
0
0
Sr VP & Chief Medical Officer
Stock Option (Right to Buy)
1.50
2014-12-04
4
A
0
50000
0
A
2014-12-04
2024-12-03
Common Stock
50000
50000
D
The stock option vested immediately as to 12,500 shares and vests as to the remainder at a rate of 3,125 shares on each three (3) month anniversary of December 4, 2014.
/s/ Richard Straube
2014-12-08